Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
By S. Palmer, A. Hayen, Petra Macaskill, F. Pellegrini, J. Craig, G. Elder, G. Strippoli. Journal of the American Medical Association (JAMA), 2011
717 citations recorded by the source corpus.
Subfields: Nephrology, Orthopedics and Sports Medicine, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/5e3d8a4fb1232c78a749054b34eb0e339344fb7d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
In Pathology and Forensic Medicine
Citations in the corpus
- Assessing Bias in Studies of Prognostic Factors (2013, methodology): “Since 2007, preliminary versions and subsequently a refined electronic version of the QUIPS tool were shared with and adapted by other research teams conducting systematic reviews of studies addressing prognosis, including review teams in rheumatology (10), cardiovascular disease (11, 12), and kidne”
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease (2011, result): “However, a recent meta-analysis demonstrated the poor relationship between parathyroid hormone and mortality, and the modest effect of elevated serum phosphate.(22)”